Oral phosphodiesterase-5 inhibitors: Effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue

Andrologia

Volumn 39, Issue 2, 2007, Pages 66-70

  Abdel Aziz, M T ^a   Mostafa, T ^a   Atta, H ^a   Rashed, L ^a   Marzouk, S A ^a   Obaia, E M ^a   Sabry, D ^a   Hassouna, A A ^a   El Shehaby, A M ^a   Abdel Aziz, A T ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

cGMP; Erectile dysfunction; Heme oxygenase; PDE inhibitors; Sildenafil; Tadalafil; Vardenafil

Indexed keywords

CYCLIC GMP; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROTOPORPHYRIN ZINC; SILDENAFIL; TADALAFIL; VARDENAFIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ENZYME INHIBITION; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TISSUE LEVEL;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CARBOLINES; CYCLIC GMP; HEME OXYGENASE (DECYCLIZING); IMIDAZOLES; MALE; PENIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; TRIAZINES;

EID: 34147169896     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2007.00765.x     Document Type: Article

References (32)

1. Abdel Aziz MT, El-Asmar MF, Mostafa T, Atta H, Abdel Aziz M, Fouad H, Roshdy N, Rashed L, Sabry D (2005) Effects of nitric oxide synthase and heme oxygenase inducers and inhibitors on molecular signaling of erectile function. Clin Biochem Nutr (Japan) 37:103-111.
2. Abraham NG, Lutton JD, Levere RD (1985) Heme metabolism and erythropoiesis in abnormal iron states. Role of aminolevulinic acid synthase and heme oxygenase. Exp Haematol 13:833-843.
3. Bloch W, Klotz T, Sedlaczek P, Zumbe J, Engelmann U, Addicks K (1998) Evidence for the involvement of endothelial nitric oxide synthase from smooth muscle cells in the erectile function of the human corpus cavernosum. Urol Res 26:129-135.
4. Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD (2004) Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 66:144-152.
5. Brouard S, Otterbein LE, Anrarther J (2000) Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1026.
6. Burnett AL (2002) Nitric oxide regulation of penile erection: biology and therapeutic implications. J Androl 23:S20-S26.
7. Chen Q, Wang N, Yao F, Lu X (2004) Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction. Zhonghua Nan Ke Xue 10:302-304.
8. 2+ activated Cl-currents in the rabbit corpus cavernosum by the nitric oxide cGMP pathway. J Physiol 556:495-506.
9. Durante W (2003) Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 195:373-382.
10. Foresti R, Motterlini R (1999) The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 31:459-475.
11. Giuliano F, Rampin O (2004) Neural control of erection. Physiol Behav 83:189-201.
12. Giuliano FA, Rampin O, Benoit G, Jardin A (1995) Neural control of penile erection. Urol Clin North Am 22:747-766.
13. Hedlund P, Aszodi A, Pfeifer A, Alm P, Hofmann F, Ahmad M, Fassler R, Andersson KE (2000) Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc Natl Acad Sci U S A 97:2349-2354.
14. Ingi T, Cheng J, Ronnett GV (1996) Carbon monoxide: an endogenous modulator of the nitric oxide-cGMP signaling system. Neuron 16:835-842.
15. Liu HJ, Mount DB, Nasjletti A, Wang WH (1999) Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. J Clin Invest 103:963-970.
16. Maines MD (2004) The heme oxygenase system: past, present, and future. Antioxid Redox Signal 6:797-801.
17. Mingone CJ, Gupte SA, Quan S, Abraham NG, Wolin MS (2003) Influence of heme and heme oxygenase-1 transfection of pulmonary microvascular endothelium on oxidant generation and cGMP. Exp Biol Med 228:535-539.
18. Mizusawa H, Hedlund P, Brioni JD, Sullivan JP, Andersson KE (2002) Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat. J Urol 167:2276-2281.
19. Morse D, Pischke SE, Zhou Z (2003) Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278:36993-36998.
20. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM (1998) HO-1 derived CO contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83:568-577.
21. Nakao A, Neto JS, Kannos S (2005) Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5:282-291.
22. Paget GE, Barnes GM (1964) Evaluation of Drug Activities, Vol. 1. Academic Press, London.
23. Pickard RS, Powell PH, Zar MA (1995) Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum. Br J Urol 75:516-522.
24. Porst H, Lunglmayr G (2005) Efficacy and tolerability of vardenafil within the time window of 6 h after administration and beyond. Results of a clinical study carried out in 233 urological offices. MMW Fortschr Med 147 (Suppl. 1): 27-32.
25. Rich A, Farrugia G, Rae JL (1994) Carbon monoxide stimulates a potassium selective current in rabbit corneal epithelial cells. Am J Physiol 267 (1 Pt 1): C435-C442.
26. Roberto M, Brian EM, Roberta F (2005) Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Invest Drugs 14:1305-1318.
27. Ryter SW, Morse D, Choi AM (2004) Carbon monoxide: to boldly go where NO has gone before. Sci STKE 20:RE6.
28. Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJJ, Sarathchandra P, Green CJ (1998) Carbon monoxide is the major contributor to the regulation of vascular tone in aortas expressing high levels of heme oxygenase-1. Br J Pharmacol 125:1437-1444.
29. Schwarz ER, Kapur V, Rodriquez J, Rastogi S, Rosanio S (2006) The effects of phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res 21:135-140.
30. Wang R, Wang Z, Wu L (1997) Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121:927-934.
31. Wang J, Lu S, Moenne P, Montellano OR (2003) Interaction of nitric oxide with human heme oxygenase-1. J Biol Chem 278:2341-2347.
32. Wright PJ (2006) Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pract 60:967-975.